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T lymphocytes play critical roles in a series of important 
immune responses, including delayed-type hypersensitivity 
and contact sensitivity. Metal haptens such as nickel are 
among the most common sensitizers. 
In general, T cells recognize fragments of proteins com-
plexed to MHC molecules. Haptens, however, are too small 
to be antigenic by themselves. Recent experiments have sug-
T he antigen-specific immune response is initiated by CD4+ T lymphocytes that are activated by the anti-gen bound to a relevant major histocompatibility complex (MHC) class II protein on the surface of antigen-presenting cells (APCs) [1]. Recognition of 
MHC proteins complexed with pep tides derived from protein anti-
gen stimulates DNA synthesis and cell division, and causes the 
release of lymphokines that mediate T-cell function [2] . Recently. 
much progress has been made in understanding the processing of 
proteins and presentation of their fragments by MHC molecules on 
the surface of APCs [3]. 
There is no evidence for the binding of nonpeptidic compounds 
to the "antigen-presenting groove" of MHC class I and class II 
molecules; however. in functional assays both class I and class II 
restricted T cells have been identified that recognized nonpeytidic 
compounds such as trinitrophenyl (TNP) [4,5]. fluorescine l6]. or 
metals (which may be referred to as haptens) [7 -9]. Most interest-
ingly, 'metal-specific T cells have been implicated in several human 
diseases, in particular in patients with contact hypersensitivity [10]. 
Contact hypersensitivity is aT -cell- dependent inflammatory re-
sponse usually manifested as an eczematous reaction at the site of 
contact with the allergen. Metal haptens such as nickel are among 
the most common allergens . Because of their complexity and clini-
cal importance, the molecular basis of recognition of haptens has 
intrigued basic and clinical immunologists for a long time. 
In this review I summarize experiments that suggest that T cells 
recognize metal-hapten-modified MHC-peptide complexes. 
METAL RECOGNITION BY T CELLS IS MHC RESTRICTED 
We studied T-cell responses to nickel or gold in patients with nickel 
or gold contact dermatitis, respectively. In both cases. nickel- or 
gold-specific CD4+ T-cell clones were isolated from patients' pe-
ripheral blood mononuclear cells [7,9]. To determine whether 
MHC molecules are involved in metal recognition, we have studied 
the response of these clones using a panel of APCs with different 
HLA isotypes. The results were clear: the clones responded to the 
nickel in association with HLA-DRwll [7] and to gold in associa-
tion with DRI [9] or DNA (Romagnoli P, Sinigaglia F, unpub-
lished). Using similar methods. other investigators also have shown 
MHC class II restriction of nickel-specific responses of peripheral 
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blood mononuclear cells [8.11] and of T-cell lines, obtained from 
tissue biopsies of patients with nickel-contact dermatitis [12]. Fur-
thermore, Saltini et al isolated and characterized beryllium-specific 
T-cell lines from lung biopsies of patients with chronic beryllium 
disease [13] . The beryllium-specific T cells were all CD4+. Anti-
class II, but not anti-class I antibodies inhibited beryllium-induced 
proliferation. Taken together, these results indicate that, in general, 
haptens are recognized by T cells in the context of self-MHC class 11 
gene products, just as are peptide antigens. 
T CELLS RECOGNIZE HAPTEN-MODIFIED PEPTIDES 
The finding that metal recognition by T cells is MHC restricted 
suggests that the metal modifies the structure of the MHC mole-
cules, the bound peptide, or both, and that it is the modified struc-
ture that is recognized by the T cells. To distinguish between these 
possibilities we studied the molecular interaction of contact sensi-
tivity-inducing Ni++ ions with the MHC peptide complex by ana-
lyzing, in a competition assay, the effect of nickel on peptide pre-
sentation to DRwll -restricted T cells [14]. The competition assay is 
based on the proliferative response of a "test T-cell clone" to a "test 
peptide" (Fig 1). It allows one to investigate whether nickel can 
inhibit the reaction by directly modifying the specific MHC mole-
cule or by altering the antigenic peptide, either before or after its 
association with the MHC protein lIS]. 
Initially we used two DRwll-restricted T-cell clones specific for 
different peptides. Nickel inhibited the response of one of the clones 
tested. There are two possible interpretations for this finding. By 
binding to MHC molecules nickel may prevent the subsequent 
binding of the peptide, or by binding to the MHC-associated pep-
tide it may modify the structure of the complex, rendering it no 
longer recognizable by the peptide-specific T cells. We showed that 
the latter was the case by treating APCs first with nickel and then 
with peptide, and vice versa. Pretreatment with nickel before puls-
ing with the peptide did not inhibit the subsequent stimulation of 
the peptide-specific T-cell clone. However, when the APCs were 
first pulsed with the peptide and then treated with nickel, we ob-
served the same inhibition as with APCs that were incubated with a 
mixture of the peptide and nickel. Thus, the interaction of nickel 
with the MHC-associated peptide modifies the peptide such that it 
is no longer recognized by the peptide-specific T-cell clone. Nickel 
appears not to interact with all peptides, because recognition of the 
other peptide tested was not inhibited by nickel treatment. Because 
histidine residues are known to interact with nickel we suspected 
that nickel interacted with histidine at position 6 of the peptide that 
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Figure 1. Schematic representation of the competition assay to evaluate the 
effect of nickel on peptide presentation. Solid circle, antigenic peptide; X, 
nickel; T H' helper T cell. 
was susceptible to inhibition. To test this possibility we synthesized 
and tested a variant peptide in which the histidine was replaced by 
lysine. Interestingly, the variant peptide was still recognized by the 
peptide-specific T-cell clone but this recognition was no longer 
inhibitable by nickel. The crucial role of the histidine residue in the 
interaction of nickel with the peptide in solution was confirmed by 
n uclear magnetic resonance (NMR) spectroscopy. Interaction of 
nickel with the histidine-containing peptide was apparent from the 
dramatic change in the NMR spectrum. In contrast, no interaction 
with nickel was evident in the case of the lysine-variant peptide 
[1 4]. These results provided the first evidence for the physical inter-
action of a hapten with an MHC-bound peptide. 
Non-metal haptens appear to be recognized in a similar way by T 
cells. Nalefski and Rao have recently shown that the ligand recog-
nized by the p-azobezenarsonate - specific T cell is a complex of a 
haptenated peptide bound to the mouse I-Ad molecule. They identi-
fied a peptide fragment, generated by enzymatic cleavage of arson-
ate-conjugated ovalbumin, which stimulates an arsonate-specific 
T-cell clone. The corresponding synthetic peptide, when conju-
gated with arsonate, was efficiently recognized by the arsonate-spe-
cifi.c T cells [16]. Similarly, Weltzien et al have shown that TNP-
reactive cytotoxic T cells also recognize a hapten-modified peptide, 
in this case bound to a mouse class I MHC molecule. Several TNP-
specific, H-2Kb-restricted mouse CTL clones were identified, 
which specifically lysed target cells in the ~resence of tryptic digests 
of TNP-modified bovine serum albumin [17]. 
ONE T CELL CAN RECOGNIZE A HAPTEN IN 
ASSOCIATION WITH DIFFERENT PEPTIDES 
In MHC-binding peptides that were isolated from class I or class II 
molecules one or few amino acids recur at certain positions with 
very high frequencies. Such residues, called "anchor" residues, are 
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Figure 2. A simplified view of the different mode of interaction of nickel 
and gold with MHC class II molecules. Class II molecules hold peptides of 
12 to 25 reSidues by anchonng two or th ree peptide side chains into comple-
mentary pockets of the class II groove. The MH C-associated nickel peptides 
ma~ be formed by cellular processing of nickel-modi1i.ed proteins or by 
conjugatIOn of l1lckel to pepndes already bound to the binding groove of 
MHC molecules. 
characteristic for each class lor class II allele examined and therefore 
define distinct sequence motifs for peptide binding to a given MHC 
molecule [18- 21]. The side chains of the anchor residues interact 
with specific pock.ets in the peptide-binding groove (Fig 2) [22 -
24]. Whereas peptldes mteract with both the groove of the present-
in~ MHC mo~ecule and theT-cell receptor (TCR), haptens appear 
to mteract mamly or exclUSIvely with the T CR. Thus, Martin et al 
s!lowed th~t .several TNP-specific T-cell clones reacted with pep-
tIdes comal.nmg the MHC class I Kb-binding motif (octamers with 
l'henyialanlll~ or.tyr~sme ~nd leucine in positions 5 and 8, respec-
tI.vely), but differing I~ theIr remaining amino acid sequences, pro-
VIded that they contallled a TNP-conjugated lysine in position 4 
[25]. T~ese. result~ indicated that T N P may be attached to any 
MHC-bmdll1g, lys1l1e-conta1ll1l1g peptIde and that various peptide-
TNP / MHC complexes are recognized by the same T cell. A similar 
situation has also been reported for TNP-specific class II-restricted 
T-cell lines. • TNP-reactive, I-Ab-, I-Ad_, and I-Ed-restricted T-cell 
lines proliferated in response to tryptic peptides from TNP-bovine 
serum albumlll and synthetic TNP peptides. Some of the T-cell 
clones were crossreactive to TNP peptides of different sequences. 
Nickel interacts with peptide-MHC class II complexes at the cell 
sur~ace. The peptides are diverse; in cells not exposed to foreign 
antigens they are all derived from a potentially very large number of 
self proteins. It is conceivable that nickel interacts with several such 
self peptides and that at least some T cells recognize a diverse set of 
nickel-modified peptides. 
T cells that recognize haptens irrespective of the structure of the 
carrier peptide are likely to be confronted with TCR ligands at 
higher densities than T cells that recognize the side chains of one 
particular peptide only. It has been speculated that CD4+ T cells not 
• Kohler], Martin S, Weltzien HU: Hapten-peptides as antigenir 
topes for class II MHC-res tricted, TNP-specific, CD4+ T cells. 1m ... 
189:57, 1993 
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only recognize peptide-MHC complexes but somehow are also able 
to "sense" the density ofTCR ligands on the surface of APCs i.e., to 
respond differently to high- and low-density TCR ligands [26,27]. 
High-density ligands favor the development of so-called Th1 cells, 
which secrete IFN-y and tumor necrosis factor (TNF) , whereas 
low-density ligands favor the development of so-called Th2 cells, 
which secrete IL-4 and IL-5 [28 ,29]. Th1 responses that are respon-
sible for contact hypersensitivity [30] may be preferentially induced 
by h.aptens such as TNP and Ni, which generate ligands at high 
density on the surface of APCs. 
GOLD INTERACTION WITH MHC CLASS II MOLECULES 
Gold salts have long been used to slow or stop the progression of 
rheumatoid arthritis [31,32] . Unfortunately, in up to one-third of 
the patients the treatment with gold has to be stopped because of 
toxicity [33] . The most common toxic effects are delayed-type hy-
persensitivity reactions involving the skin and mucous membranes. 
Although different mechanisms have been proposed, based upon 
various effects of gold compounds observed in a number of different 
model systems [34] , an adequate explanation for the therapeutic 
effect and/or the toxic reactions has remained elusive. Recently, we 
have shown that gold salts, as nickel, inhibited peptide-induced 
responses of peptide-specific T -cell clones [9]. Several lines of evi-
dence, however, suggested that, unlike nickel, gold binds directly to 
the MHC class II molecule (Fig 2) . First, we have shown that in a 
competition assay, pretreatment of the antigen-presenting cells 
with gold before pulsing with the antigenic peptide results in com-
plete inhibition of the peptide-induced proliferation. t Second, by 
incubating radioactive gold with a panel of class II-positive and 
-negative cell lines, we could demonstrate the direct binding of gold 
to class II molecules. t Further studies will be needed to determine 
the structural basis for gold binding to MHC class II molecules and 
whether other molecules, distinct from MHC but contributing to 
T-cell ~ctivation, might also be involved in interaction with gold . 
In a ny case, the available data provide an explanation for both the 
therapeutic and toxic effects of gold treatment. Modification of the 
putative "autoimmune peptide-MHC complexes" by gold may 
prevent the stimulation of auto reactive T cells in RA, and may, at 
the same time, elicit gold-specific T cells responsible for the de-
layed-type hypersensitivity reactions that are observed in some pa-
tients. 
THE ROLE OF MHC GENE PRODUCTS IN HAPTEN-
SPECIFIC T CELL RESPONSES 
T _cell clones with specificity for hap tens have been shown, in gen-
era l, to recognize hapten-modified peptides in association with 
MHC class II molecules on the surface of the antigen-presenting 
cel l. Genes of the MHC class II (HLA-DR, -DQ, and -DP) that are 
associated with susceptibility to autoimmune disorders [35,36] are 
likely candidates as susceptibility genes in metal allergies. Indeed, 
Richeldi e/ aJ [37], examining the MHC class II genes in 33 cases 
with chronic beryllium disease and 44 controls, have shown a nega-
tive association with HLA-DPB 1 ·0401 and a positive association 
with HLA-DPB1 · 0201 alleles. Interestingly, the two DP alleles 
differ in only a few residues of the MHC-binding site. More contro-
versial findin gs have been reported for nickel allergy. The initial 
association between nickel allergy and HLA-DQA genes [~] could 
not be confirmed [39]. Thus, the involvement of MHC molecules 
in susceptibility to metal allergies seems to be variable, depending 
on which metal one examines. As discussed, metals, via their chemi-
cally reactive groups , could attach themselves to peptides bound to 
MHC molecul es and induce MHC-restricted responses to the con-
t Romagnoli P , Takacs B, Sinigaglia F: Immuno logically relevant bind-
in g of gold to HLA-DR molecules (in preparation) 
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jugates. Variations in the family of peptides, influenced by MHC 
polymorphism, could account, at least in part, for differences in ease 
of sensitization to such agents. 
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ESDR ANNUAL MEETING 
The 24th Annual Meeting of the European Society for Dermatological Research (ESDR) will 
be held September 24- 27, 1994 at the Vienna General Hospital , Vienna, Austria. As a leading 
forum for research in dermatology and skin biology, the ESDR provides a broad platform for 
the presentation of the latest scientific results in the form of oral or poster communications. The 
program will be highlighted by guest lectures from renowned scientists on new and exciting 
developments in molecular and cellular biology and their impact on dermatology. The closing 
date for submission of abstracts is May 20, 1994. 
Abstract forms and meeting registration information can be obtained by writing to: Prof. Dr. 
Wolfram Sterry, ESDR Secretary, Department of Dermatology, University of Ulm Medical 
School , Oberer Eselsberg 40, D-89081 ULM, Germany. Fax:: 49-731-502-3772. 
